341 related articles for article (PubMed ID: 25065597)
1. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis.
Josson S; Gururajan M; Sung SY; Hu P; Shao C; Zhau HE; Liu C; Lichterman J; Duan P; Li Q; Rogatko A; Posadas EM; Haga CL; Chung LW
Oncogene; 2015 May; 34(21):2690-9. PubMed ID: 25065597
[TBL] [Abstract][Full Text] [Related]
2. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.
Gururajan M; Josson S; Chu GC; Lu CL; Lu YT; Haga CL; Zhau HE; Liu C; Lichterman J; Duan P; Posadas EM; Chung LW
Clin Cancer Res; 2014 Dec; 20(24):6559-69. PubMed ID: 25324143
[TBL] [Abstract][Full Text] [Related]
3. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.
Josson S; Gururajan M; Hu P; Shao C; Chu GY; Zhau HE; Liu C; Lao K; Lu CL; Lu YT; Lichterman J; Nandana S; Li Q; Rogatko A; Berel D; Posadas EM; Fazli L; Sareen D; Chung LW
Clin Cancer Res; 2014 Sep; 20(17):4636-46. PubMed ID: 24963047
[TBL] [Abstract][Full Text] [Related]
4. microRNAs and Prostate Cancer.
Josson S; Chung LW; Gururajan M
Adv Exp Med Biol; 2015; 889():105-18. PubMed ID: 26658999
[TBL] [Abstract][Full Text] [Related]
5. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
6. Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy.
Taddei ML; Cavallini L; Ramazzotti M; Comito G; Pietrovito L; Morandi A; Giannoni E; Raugei G; Chiarugi P
J Cell Physiol; 2019 Jun; 234(6):8274-8285. PubMed ID: 30378132
[TBL] [Abstract][Full Text] [Related]
7. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.
Musumeci M; Coppola V; Addario A; Patrizii M; Maugeri-Saccà M; Memeo L; Colarossi C; Francescangeli F; Biffoni M; Collura D; Giacobbe A; D'Urso L; Falchi M; Venneri MA; Muto G; De Maria R; Bonci D
Oncogene; 2011 Oct; 30(41):4231-42. PubMed ID: 21532615
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
[TBL] [Abstract][Full Text] [Related]
9. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
10. Enhancing HOTAIR/MiR-10b Drives Normal Liver Stem Cells Toward a Tendency to Malignant Transformation Through Inducing Epithelial- to-Mesenchymal Transition.
Ye P; Wang T; Liu WH; Li XC; Tang LJ; Tian FZ
Rejuvenation Res; 2015 Aug; 18(4):332-40. PubMed ID: 25708830
[TBL] [Abstract][Full Text] [Related]
11. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM.
Voss G; Haflidadóttir BS; Järemo H; Persson M; Catela Ivkovic T; Wikström P; Ceder Y
Carcinogenesis; 2020 Jul; 41(7):865-874. PubMed ID: 31738404
[TBL] [Abstract][Full Text] [Related]
13. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
14. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
Zhiping C; Shijun T; Linhui W; Yapei W; Lianxi Q; Qiang D
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4835-4843. PubMed ID: 29164579
[TBL] [Abstract][Full Text] [Related]
15. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
Du X; Tu Y; Liu S; Zhao P; Bao Z; Li C; Li J; Pan M; Ji J
J Cell Mol Med; 2020 Jan; 24(2):1474-1487. PubMed ID: 31856394
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo.
Sahranavardfard P; Firouzi J; Azimi M; Khosravani P; Heydari R; Emami Razavi A; Dorraj M; Keighobadi F; Ebrahimi M
J Cell Physiol; 2019 Nov; 234(11):20193-20205. PubMed ID: 31016725
[TBL] [Abstract][Full Text] [Related]
17. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.
Liu YN; Yin JJ; Abou-Kheir W; Hynes PG; Casey OM; Fang L; Yi M; Stephens RM; Seng V; Sheppard-Tillman H; Martin P; Kelly K
Oncogene; 2013 Jan; 32(3):296-306. PubMed ID: 22370643
[TBL] [Abstract][Full Text] [Related]
18. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
[TBL] [Abstract][Full Text] [Related]
19. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
[TBL] [Abstract][Full Text] [Related]
20. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R
Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
